Suchergebnisse - "Emmungil, Hakan"

PubPharm (86)

11

The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs : Outcomes from the TReasure Real-Life Database

enthalten in: European journal of rheumatology | 2022

von Alpay Kanıtez, N. | Kiraz, S. | Dalkılıç, E. | +20

12

EGFR blocker lapatinib inhibits the synthesis of matrix metalloproteinases from synovial fibroblasts

enthalten in: Turkish journal of medical sciences | 2022

von Kehribar, D. | Emmungil, H. | Türkmen, N. | +3

13

Imaging in myositis : MRI or 18F-FDG PET/CT?

enthalten in: Clinical rheumatology | 2022

von İlgen, U. | Emmungil, H.

14

Tuberculin Skin Test in Spondyloarthritis: Overestimated if Rheumatoid Arthritis Guidelines for Latent Tuberculosis Are Used?

enthalten in: ResearchSquare.com | 2022

von İlgen, U. | Karadağ, �. | Emmungil, H. | +20

15

Tuberculin skin test before biologic and targeted therapies: does the same rule apply for all?

enthalten in: Rheumatology international | 2022

von İlgen, U. | Karadağ, �. | Emmungil, H. | +20

16

Tuberculin skin test before biologic and targeted therapies: does the same rule apply for all?

enthalten in: Rheumatology international | 2022

von İlgen, U. | Karadağ, �. | Emmungil, H. | +20

17

Pigmented villus fragments on synovial fluid examination

enthalten in: European journal of rheumatology | 2022

von İlgen, U. | Emmungil, H.

18

Imaging in myositis: MRI or 18F-FDG PET/CT?

enthalten in: Clinical rheumatology | 2022

von İlgen, U. | Emmungil, H.

19

Imaging in myositis: MRI or 18F-FDG PET/CT?

enthalten in: Clinical rheumatology | 2022

von İlgen, U. | Emmungil, H.

20

Enteropathic Arthritis Beyond the Criteria

enthalten in: Inflammatory bowel diseases | 2022

von İlgen, U. | Emmungil, H.